Home > Journals > Minerva Endocrinology > Past Issues > Minerva Endocrinology 2021 December;46(4) > Minerva Endocrinology 2021 December;46(4):384-8



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as



Minerva Endocrinology 2021 December;46(4):384-8

DOI: 10.23736/S2724-6507.20.03357-X


language: English

GPR56 gene down-regulation in patients with Klinefelter Syndrome: a candidate for infertility?

Michele SALEMI 1, Rossella CANNARELLA 2 , Laura CIMINO 2, Rosita A. CONDORELLI 2, Giorgio GIURATO 3, Giovanna MARCHESE 3, Angela CORDELLA 3, Sandro SANTA PAOLA 1, Corrado ROMANO 1, Sandro LA VIGNERA 2, Aldo E. CALOGERO 2

1 Oasi Research Institute-IRCCS, Troina, Enna, Italy; 2 Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; 3 Genomix4Life Srl, Schola Medica Salernitana Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Salerno, Italy

BACKGROUND: The etiology of azoospermia in patients with Klinefelter Syndrome (KS) is still unknown. The protein codified by the G protein-couple receptor 56 (GPR56) belongs to the adhesion family of G protein-coupled receptors (GPRs). Its mutations are involved in the pathogenesis of intellectual disability and, according to animal studies, infertility. As the expression of GPR56 in patients with KS has not been investigated so far, this study was undertaken with the purpose of evaluating its expression in peripheral blood mononuclear cells (PBMCs) of patients with KS and normal controls.
METHODS: This age-matched case-control study was performed in 10 patients with KS and 10 controls. Patients and controls underwent to blood sampling for next-generation sequencing (NGS) analysis, and differentially expressed mRNAs were identified using DESeq2 v.1.12. QRT-PCR was used to validate the results obtained by NGS analysis. TaqMan Gene Expression Assay primers were used to carry out the real-time PCR analysis for GPR56.
RESULTS: GPR56 was down-regulated by -2081-fold (q-value <0.05) in PBMCs of patients with KS compared to controls. NGS data were confirmed by QRT-PCR.
CONCLUSIONS: The possible contribution of the GPR56 gene down-regulation in the pathogenesis of spermatogenic failure in patients with KS is worthy to be further explored.

KEY WORDS: Klinefelter Syndrome; Male infertility; Intellectual disability; Human GPR56 protein; Germ cells

top of page